Results 161 to 170 of about 1,972 (243)

What anabolic–androgenic steroids reveal about the limits of current harm reduction models

Addiction, Volume 121, Issue 11, Page 2861-2869, November 2026.
Abstract Background Harm reduction has largely been shaped by responses to psychoactive drug use where the most urgent harms are acute. These models focus on overdose, blood‐borne viruses, and rapid‐onset toxicity related harms. When applied wholesale to anabolic–androgenic steroids (AAS), they obscure the distinctive pharmacology, consumer typologies,
Timothy Piatkowski, Jason M. Nagata, Suzanne Nielsen   +2 more
wiley   +1 more source

Aligned electrospun porous P34HB/lecithin scaffold for bone tissue regeneration. [PDF]

Sci Rep
Liu W, Wang P, Wang Z, Yang H, Yu G, Sui L, Fu N.   +6 more
europepmc   +1 more source

Improving the Mechanical Properties of Biodegradable Polyhydroxyalkanoates via PHA–PHA Block‐Copolymer Synthesis

Chemistry – A European Journal, Volume 32, Issue 39, 22 October 2026.
Covalent linkage of a highly crystalline PHBV with a ductile P3HB4HB is shown to produce block copolymers with markedly enhanced extensibility and toughness, outperforming equivalent blends. The results demonstrate that polymer architecture, not composition alone, governs mechanical response, offering a route to biodegradable materials that combine ...
Katrin Blandine Kockler, Paul Lant, Steven Pratt, Bronwyn Laycock   +3 more
wiley   +1 more source

Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis. [PDF]

Front Immunol
Robertson D, Alvarez E, Steinman L, Hartung HP, Qian P, Selmaj K, Wray S, Wynn D, Fox EJ, Mok K, Miskin HP, Xu Y, Garner CA, Cree BAC.   +13 more
europepmc   +1 more source

Fifteen-year real-world pharmacovigilance of multiple sclerosis disease-modifying therapies: adverse event profiles, drug-specific safety signals and clinical implications. [PDF]

Front Neurol
Lin S, Zhang B, Zhang Y, Zhang X, Li Y, Zhang W, He L.   +6 more
europepmc   +1 more source

Serine Protease HtrA2 from Halophilic Archeon <i>Haloarcula</i> sp. TG1: Heterologous Expression, Characterization and Immobilization. [PDF]

Biomolecules
Kurt-Kızıldoğan A, Konuksever Ö, Yavuz Ö, Otur Ç, Abanoz-Seçgin B, Okay S.   +5 more
europepmc   +1 more source

Regulation of central carbon metabolism and storage polymers by PTS^Ntr in <i>Rhizobium leguminosarum</i>. [PDF]

Appl Environ Microbiol
Tjahjono O, Wang J, Turner E, Prell J, Huang WE, Poole PS, Sánchez-Cañizares C.   +6 more
europepmc   +1 more source

Production of poly(3-hydroxybutyrate) by Rhodococcus qingshengii N9T-4 using the oligotrophic gene expression system. [PDF]

Sci Rep
Otsuka A, Orita I, Yurimoto H, Yoshida N.   +3 more
europepmc   +1 more source

Controlled biodegradability of polyhydroxybutyrate via surface coating with cellulose triacetate. [PDF]

Sci Rep
Chae YJ, Lee TG.
europepmc   +1 more source

Long-Term Outcomes After Slowly Resorbable P4HB Mesh Implantation: A Multicenter Analysis From European Registry. [PDF]

World J Surg
van den Berg R, Wieser M, López-Cano M, Bueno-Lledó J, Köckerling F, Chatzimavroudis G, Gonella-Pacchiotti C, Stabilini C, Ortega-Deballon P, Romain B, PRS Group (Phasix Research Study Group).   +10 more
europepmc   +1 more source